United States Antidiabetics Drug Market Report 2017

August 2017 | 100 pages | ID: UB5E0DFE72FEN
QYResearch

Abstracts

In this report, the United States Antidiabetics Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antidiabetics Drug in these regions, from 2012 to 2022 (forecast).

United States Antidiabetics Drug market competition by top manufacturers/players, with Antidiabetics Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Bayer
• Boehringer Ingelheim
• Eli-Lilly
• Johnson & Johnson
• Merck
• Novartis
• Novo Nordisk
• Sanofi

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Metformin (Biguanides)
• Insulin Sensitization Agent (TZD Use)
• Sulfonated Ideal Urea Class
• Meglitinides
• Alpha Glucosidase Inhibitors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antidiabetics Drug for each application, including

• Hospital
• Household

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antidiabetics Drug Market Report 2017

1 ANTIDIABETICS DRUG OVERVIEW

1.1 Product Overview and Scope of Antidiabetics Drug
1.2 Classification of Antidiabetics Drug by Product Category
  1.2.1 United States Antidiabetics Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antidiabetics Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Metformin (Biguanides)
  1.2.4 Insulin Sensitization Agent (TZD Use)
  1.2.5 Sulfonated Ideal Urea Class
  1.2.6 Meglitinides
  1.2.7 Alpha Glucosidase Inhibitors
1.3 United States Antidiabetics Drug Market by Application/End Users
  1.3.1 United States Antidiabetics Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Household
1.4 United States Antidiabetics Drug Market by Region
  1.4.1 United States Antidiabetics Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antidiabetics Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Antidiabetics Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antidiabetics Drug Status and Prospect (2012-2022)
  1.4.5 New England Antidiabetics Drug Status and Prospect (2012-2022)
  1.4.6 The South Antidiabetics Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Antidiabetics Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antidiabetics Drug (2012-2022)
  1.5.1 United States Antidiabetics Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Antidiabetics Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIDIABETICS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antidiabetics Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antidiabetics Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antidiabetics Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Antidiabetics Drug Market Competitive Situation and Trends
  2.4.1 United States Antidiabetics Drug Market Concentration Rate
  2.4.2 United States Antidiabetics Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antidiabetics Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIDIABETICS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antidiabetics Drug Sales and Market Share by Region (2012-2017)
3.2 United States Antidiabetics Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Antidiabetics Drug Price by Region (2012-2017)

4 UNITED STATES ANTIDIABETICS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antidiabetics Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antidiabetics Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Antidiabetics Drug Price by Type (2012-2017)
4.4 United States Antidiabetics Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIDIABETICS DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antidiabetics Drug Sales and Market Share by Application (2012-2017)
5.2 United States Antidiabetics Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIDIABETICS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidiabetics Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Antidiabetics Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.2 Antidiabetics Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli-Lilly
  6.4.2 Antidiabetics Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli-Lilly Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
  6.5.2 Antidiabetics Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck
  6.6.2 Antidiabetics Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.2 Antidiabetics Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novo Nordisk
  6.8.2 Antidiabetics Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novo Nordisk Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sanofi
  6.9.2 Antidiabetics Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sanofi Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 ANTIDIABETICS DRUG MANUFACTURING COST ANALYSIS

7.1 Antidiabetics Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidiabetics Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antidiabetics Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidiabetics Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIDIABETICS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antidiabetics Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antidiabetics Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Antidiabetics Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Antidiabetics Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antidiabetics Drug
Figure United States Antidiabetics Drug Market Size (K Units) by Type (2012-2022)
Figure United States Antidiabetics Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Metformin (Biguanides) Product Picture
Figure Insulin Sensitization Agent (TZD Use) Product Picture
Figure Sulfonated Ideal Urea Class Product Picture
Figure Meglitinides Product Picture
Figure Alpha Glucosidase Inhibitors Product Picture
Figure United States Antidiabetics Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Antidiabetics Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Household Examples
Table Key Downstream Customer in Household
Figure United States Antidiabetics Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Antidiabetics Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antidiabetics Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antidiabetics Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antidiabetics Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antidiabetics Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antidiabetics Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidiabetics Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Antidiabetics Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidiabetics Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Antidiabetics Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Antidiabetics Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidiabetics Drug Sales Share by Players/Suppliers
Figure 2017 United States Antidiabetics Drug Sales Share by Players/Suppliers
Figure United States Antidiabetics Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antidiabetics Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antidiabetics Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidiabetics Drug Revenue Share by Players/Suppliers
Figure 2017 United States Antidiabetics Drug Revenue Share by Players/Suppliers
Table United States Market Antidiabetics Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Antidiabetics Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Antidiabetics Drug Market Share of Top 3 Players/Suppliers
Figure United States Antidiabetics Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antidiabetics Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antidiabetics Drug Product Category
Table United States Antidiabetics Drug Sales (K Units) by Region (2012-2017)
Table United States Antidiabetics Drug Sales Share by Region (2012-2017)
Figure United States Antidiabetics Drug Sales Share by Region (2012-2017)
Figure United States Antidiabetics Drug Sales Market Share by Region in 2016
Table United States Antidiabetics Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antidiabetics Drug Revenue Share by Region (2012-2017)
Figure United States Antidiabetics Drug Revenue Market Share by Region (2012-2017)
Figure United States Antidiabetics Drug Revenue Market Share by Region in 2016
Table United States Antidiabetics Drug Price (USD/Unit) by Region (2012-2017)
Table United States Antidiabetics Drug Sales (K Units) by Type (2012-2017)
Table United States Antidiabetics Drug Sales Share by Type (2012-2017)
Figure United States Antidiabetics Drug Sales Share by Type (2012-2017)
Figure United States Antidiabetics Drug Sales Market Share by Type in 2016
Table United States Antidiabetics Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antidiabetics Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antidiabetics Drug by Type (2012-2017)
Figure Revenue Market Share of Antidiabetics Drug by Type in 2016
Table United States Antidiabetics Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Antidiabetics Drug Sales Growth Rate by Type (2012-2017)
Table United States Antidiabetics Drug Sales (K Units) by Application (2012-2017)
Table United States Antidiabetics Drug Sales Market Share by Application (2012-2017)
Figure United States Antidiabetics Drug Sales Market Share by Application (2012-2017)
Figure United States Antidiabetics Drug Sales Market Share by Application in 2016
Table United States Antidiabetics Drug Sales Growth Rate by Application (2012-2017)
Figure United States Antidiabetics Drug Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Bayer Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Bayer Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Eli-Lilly Basic Information List
Table Eli-Lilly Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli-Lilly Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Eli-Lilly Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Eli-Lilly Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Merck Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Merck Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Novartis Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Novartis Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Novo Nordisk Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Novo Nordisk Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Antidiabetics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Antidiabetics Drug Sales Growth Rate (2012-2017)
Figure Sanofi Antidiabetics Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Antidiabetics Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetics Drug
Figure Manufacturing Process Analysis of Antidiabetics Drug
Figure Antidiabetics Drug Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetics Drug Major Players/Suppliers in 2016
Table Major Buyers of Antidiabetics Drug
Table Distributors/Traders List
Figure United States Antidiabetics Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Antidiabetics Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antidiabetics Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Antidiabetics Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Antidiabetics Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Antidiabetics Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Antidiabetics Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Antidiabetics Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Antidiabetics Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Antidiabetics Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Antidiabetics Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidiabetics Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidiabetics Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources